Home / Healthcare / Capsule Endoscopy Market

Capsule Endoscopy Market Size, Share And Global Trend By Product (Oesophageal Capsule, Small Bowel Capsule,Colon Capsule), By Application (Obscure Gastrointestinal Bleeding, Crohn Disease, Small Intestine Tumor), By End User (Hospitals, Diagnostic Laboratories, Specialty Clinics), And Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI100597 | Status : Upcoming

Capsule endoscopy is used to examine the gastrointestinal tract. Capsule endoscopy is a vitamin-sized capsule consisting of a small sized camera. Several images are captured by the tiny camera, once the capsule is swallowed by the patient which are transmitted to a recorder on the waist belt provided to the patient. Capsule endoscopy allows physicians to detect infections and abnormalities in gastrointestinal track to give accurate and better treatment. CapsoCam Plus by CapsoVision is the only capsule endoscope embedded with four cameras and offering 360 degree panoramic lateral imaging of the small colon.


The rise in a number of chronic diseases such as cancer and gastrointestinal diseases in developed as well as developing countries are some of the factors expected to drive the growth of the global capsule endoscopy market. Advancement in capsule endoscopy technology and hybrid imaging techniques, increase in a shift of patients towards the advanced diagnostics is one of the major factor driving the growth of the global capsule endoscopy market.



However, the high cost of the diagnostic procedure, inadequate reimbursement policies and the risk of capsule retention inside the patient’s body are some of the factors anticipated to restrain the growth of the global capsule endoscopy market.


Key Players Covered


Some of the major companies that are present in the global Capsule Endoscopy market are MEDTRONIC, Olympus Corporation, IntroMedic Co., Ltd., JINSHAN Science & Technology, Fujifilm Holding Corporation, CapsoVision, RF System lab, and others.


SEGMENTATION


























SEGMENTATION



 DETAILS



By Product



·         Oesophageal Capsule


·         Small Bowel Capsule


·         Colon Capsule.



By Application



·         Obscure Gastrointestinal Bleeding (OGIB)


·         Crohn’s Disease


·         Small Intestine Tumor


·         Other.



By End User



·         Hospitals


·         Diagnostic Laboratories


·         Specialty Clinics



By Geography



·         North America (USA and Canada)


·         Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


·         Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


·         Latin America (Brazil, Mexico and Rest of Latin America)


·         Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


Use of capsule endoscopy for the diagnosis of the Obscure Gastrointestinal Bleeding is expected to drive the growth of the global capsule endoscopy market, owing to clinically established efficiency and superiority over barium x-rays of capsule endoscopy in diagnosis of Obscure Gastrointestinal Bleeding.


Regional Analysis


The global capsule endoscopy market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to account for the largest share in the capsule endoscopy market followed by Europe. Due to the increased adoption of advanced technology, high investment in the healthcare infrastructure, high demand for minimally invasive surgeries in North America. Increasing prevalence of colorectal cancer and gastrointestinal disorders in North America is one the major factor will help to retain its leading market share in capsule endoscopy market. Asia-Pacific and Latin America are anticipated to register comparatively higher CAGR during the forecast period, owing to growing awareness of the advanced endoscopy treatments, growing aging population and numerous government initiatives taken towards the awareness of capsule endoscopy.


Key Industry Developments



  • In June 2018, Stratis Medical, Inc., become the exclusive distributor for MiroCam Capsule Endoscopy products in the United States. Stratis Medical, Inc., received FDA approval and clearance for the launch of the first and only dual-camera capsule endoscopy system for examination of the small intestine.

  • In August 2017, FUJIFILM Corporation launched two new products with advanced endoscopic platform including ClutchCutter and FlushKnife devices. These devices benefit clinicians in performing effective endoscopic submucosal dissection (ESD) interventions within the digestive tract.

  • In September 2016, Olympus Corporation launched the Visera 4K UHD system for ear, nose, and throat procedures allowing big-screen surgery with ultra-high definition endoscopy. 

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients